JAMA Psychiatry:难治性抑郁症的成本效果:电惊厥疗法vs药物治疗/心理疗法

2018-07-27 吴星 环球医学

2018年7月,发表在《JAMA Psychiatry》的一项由美国学者进行的研究,考察了电惊厥疗法(ECT)vs药物治疗/心理疗法治疗难治性抑郁症在美国的成本效果。

2018年7月,发表在《JAMA Psychiatry》的一项由美国学者进行的研究,考察了电惊厥疗法(ECT)vs药物治疗/心理疗法治疗难治性抑郁症在美国的成本效果。

重要性:ECT治疗抑郁症高度有效,但是由于会使患者感到羞辱、不确定适应证、不良反应和认为成本较高而不常用。

目的:评估在美国,ECT vs药物治疗/心理疗法治疗难治性严重抑郁障碍的成本效果。

设计、地点和参与者:整合了ECV vs药物治疗/心理疗法的临床疗效、成本和生活质量数据的决策分析模型,用于模拟在美国卫生部门的视角下,4年期间的抑郁症治疗。模型输入数据来自于抑郁症患者的多个Meta分析、随机试验和观察性研究。可能的时候,数据来源限制于基于美国非精神病性重度抑郁症的研究。2017年6月~2018年1月分析数据。

干预:将ECT结合到抑郁症治疗中(0~5线药物治疗/心理疗法失败后)的6个替代策略vs无ECT。

主要结局和测量指标:抑郁症缓解、应答和无应答;质量调整生命年;2013年美元计算的成本;以及增量成本效果比。成本效果的策略的定义为每质量调整生命年的增量成本效果比为$100000或更少。

结果:基于序贯治疗替代方案缓解抑郁症试验,研究者模拟了平均(SD)年龄为40.7(13.2)岁的人群,62.2%为女性。4年后,ECT预计可将未控制的抑郁症时间从50%生命年降至33%~37%生命年,当ECT更早进行时,改善更多。平均医疗成本增加了$7300~$12000,当ECT更早进行时,成本增量更高。在基础病例中,三线ECT是具有成本效果的,每质量调整生命年的ICER为$54000。在一系列单变量、情景和概率敏感性分析中,三线ECT仍然具有成本效果。将所有不确定的输入数据融合后,研究者估计,至少1个ECT策略具有成本效果的可能性为74%~78%,估计三线ECT是最佳策略的可能性为56%~58%。

结论和意义:对于美国难治性抑郁症患者,ECT可能是一种有效且具有成本效果的治疗选择。虽然许多因素可影响是否继续进行ECT的决策,但这些数据表明,从卫生经济学的角度来讲,可在二线或更高线的药物治疗/心理疗法失败后考虑进行ECT。

原始出处:

Ross EL, Zivin K, Maixner DF, et al. Cost-effectiveness of Electroconvulsive Therapy vs Pharmacotherapy/Psychotherapy for Treatment-Resistant Depression in the United States. JAMA Psychiatry. 2018 Jul 1;75(7):713-722. doi: 10.1001/jamapsychiatry.2018.0768.

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1955132, encodeId=bac019551321c, content=<a href='/topic/show?id=d9db98635ef' target=_blank style='color:#2F92EE;'>#难治性抑郁症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98635, encryptionId=d9db98635ef, topicName=难治性抑郁症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea13490, createdName=xqptu, createdTime=Wed Jan 16 16:33:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998836, encodeId=3748199883693, content=<a href='/topic/show?id=4694e0110e8' target=_blank style='color:#2F92EE;'>#电惊厥疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70110, encryptionId=4694e0110e8, topicName=电惊厥疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat May 11 17:33:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1792125, encodeId=5e9c1e92125ad, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Jul 11 02:33:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334914, encodeId=0dd23349146e, content=不错了,学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sun Jul 29 12:26:23 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425882, encodeId=965f1425882b5, content=<a href='/topic/show?id=83135316192' target=_blank style='color:#2F92EE;'>#惊厥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53161, encryptionId=83135316192, topicName=惊厥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff14003523, createdName=zz12341235, createdTime=Sun Jul 29 05:33:00 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528496, encodeId=fd8215284969d, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Sun Jul 29 05:33:00 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334548, encodeId=fd8633454804, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Jul 27 18:54:22 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046576, encodeId=b25c10465e60d, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Jul 27 17:33:00 CST 2018, time=2018-07-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1955132, encodeId=bac019551321c, content=<a href='/topic/show?id=d9db98635ef' target=_blank style='color:#2F92EE;'>#难治性抑郁症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98635, encryptionId=d9db98635ef, topicName=难治性抑郁症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea13490, createdName=xqptu, createdTime=Wed Jan 16 16:33:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998836, encodeId=3748199883693, content=<a href='/topic/show?id=4694e0110e8' target=_blank style='color:#2F92EE;'>#电惊厥疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70110, encryptionId=4694e0110e8, topicName=电惊厥疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat May 11 17:33:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1792125, encodeId=5e9c1e92125ad, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Jul 11 02:33:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334914, encodeId=0dd23349146e, content=不错了,学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sun Jul 29 12:26:23 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425882, encodeId=965f1425882b5, content=<a href='/topic/show?id=83135316192' target=_blank style='color:#2F92EE;'>#惊厥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53161, encryptionId=83135316192, topicName=惊厥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff14003523, createdName=zz12341235, createdTime=Sun Jul 29 05:33:00 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528496, encodeId=fd8215284969d, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Sun Jul 29 05:33:00 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334548, encodeId=fd8633454804, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Jul 27 18:54:22 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046576, encodeId=b25c10465e60d, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Jul 27 17:33:00 CST 2018, time=2018-07-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1955132, encodeId=bac019551321c, content=<a href='/topic/show?id=d9db98635ef' target=_blank style='color:#2F92EE;'>#难治性抑郁症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98635, encryptionId=d9db98635ef, topicName=难治性抑郁症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea13490, createdName=xqptu, createdTime=Wed Jan 16 16:33:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998836, encodeId=3748199883693, content=<a href='/topic/show?id=4694e0110e8' target=_blank style='color:#2F92EE;'>#电惊厥疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70110, encryptionId=4694e0110e8, topicName=电惊厥疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat May 11 17:33:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1792125, encodeId=5e9c1e92125ad, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Jul 11 02:33:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334914, encodeId=0dd23349146e, content=不错了,学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sun Jul 29 12:26:23 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425882, encodeId=965f1425882b5, content=<a href='/topic/show?id=83135316192' target=_blank style='color:#2F92EE;'>#惊厥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53161, encryptionId=83135316192, topicName=惊厥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff14003523, createdName=zz12341235, createdTime=Sun Jul 29 05:33:00 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528496, encodeId=fd8215284969d, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Sun Jul 29 05:33:00 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334548, encodeId=fd8633454804, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Jul 27 18:54:22 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046576, encodeId=b25c10465e60d, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Jul 27 17:33:00 CST 2018, time=2018-07-27, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1955132, encodeId=bac019551321c, content=<a href='/topic/show?id=d9db98635ef' target=_blank style='color:#2F92EE;'>#难治性抑郁症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98635, encryptionId=d9db98635ef, topicName=难治性抑郁症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea13490, createdName=xqptu, createdTime=Wed Jan 16 16:33:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998836, encodeId=3748199883693, content=<a href='/topic/show?id=4694e0110e8' target=_blank style='color:#2F92EE;'>#电惊厥疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70110, encryptionId=4694e0110e8, topicName=电惊厥疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat May 11 17:33:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1792125, encodeId=5e9c1e92125ad, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Jul 11 02:33:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334914, encodeId=0dd23349146e, content=不错了,学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sun Jul 29 12:26:23 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425882, encodeId=965f1425882b5, content=<a href='/topic/show?id=83135316192' target=_blank style='color:#2F92EE;'>#惊厥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53161, encryptionId=83135316192, topicName=惊厥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff14003523, createdName=zz12341235, createdTime=Sun Jul 29 05:33:00 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528496, encodeId=fd8215284969d, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Sun Jul 29 05:33:00 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334548, encodeId=fd8633454804, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Jul 27 18:54:22 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046576, encodeId=b25c10465e60d, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Jul 27 17:33:00 CST 2018, time=2018-07-27, status=1, ipAttribution=)]
    2018-07-29 owlhealth

    不错了,学习啦

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1955132, encodeId=bac019551321c, content=<a href='/topic/show?id=d9db98635ef' target=_blank style='color:#2F92EE;'>#难治性抑郁症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98635, encryptionId=d9db98635ef, topicName=难治性抑郁症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea13490, createdName=xqptu, createdTime=Wed Jan 16 16:33:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998836, encodeId=3748199883693, content=<a href='/topic/show?id=4694e0110e8' target=_blank style='color:#2F92EE;'>#电惊厥疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70110, encryptionId=4694e0110e8, topicName=电惊厥疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat May 11 17:33:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1792125, encodeId=5e9c1e92125ad, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Jul 11 02:33:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334914, encodeId=0dd23349146e, content=不错了,学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sun Jul 29 12:26:23 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425882, encodeId=965f1425882b5, content=<a href='/topic/show?id=83135316192' target=_blank style='color:#2F92EE;'>#惊厥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53161, encryptionId=83135316192, topicName=惊厥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff14003523, createdName=zz12341235, createdTime=Sun Jul 29 05:33:00 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528496, encodeId=fd8215284969d, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Sun Jul 29 05:33:00 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334548, encodeId=fd8633454804, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Jul 27 18:54:22 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046576, encodeId=b25c10465e60d, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Jul 27 17:33:00 CST 2018, time=2018-07-27, status=1, ipAttribution=)]
    2018-07-29 zz12341235
  6. [GetPortalCommentsPageByObjectIdResponse(id=1955132, encodeId=bac019551321c, content=<a href='/topic/show?id=d9db98635ef' target=_blank style='color:#2F92EE;'>#难治性抑郁症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98635, encryptionId=d9db98635ef, topicName=难治性抑郁症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea13490, createdName=xqptu, createdTime=Wed Jan 16 16:33:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998836, encodeId=3748199883693, content=<a href='/topic/show?id=4694e0110e8' target=_blank style='color:#2F92EE;'>#电惊厥疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70110, encryptionId=4694e0110e8, topicName=电惊厥疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat May 11 17:33:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1792125, encodeId=5e9c1e92125ad, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Jul 11 02:33:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334914, encodeId=0dd23349146e, content=不错了,学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sun Jul 29 12:26:23 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425882, encodeId=965f1425882b5, content=<a href='/topic/show?id=83135316192' target=_blank style='color:#2F92EE;'>#惊厥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53161, encryptionId=83135316192, topicName=惊厥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff14003523, createdName=zz12341235, createdTime=Sun Jul 29 05:33:00 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528496, encodeId=fd8215284969d, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Sun Jul 29 05:33:00 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334548, encodeId=fd8633454804, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Jul 27 18:54:22 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046576, encodeId=b25c10465e60d, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Jul 27 17:33:00 CST 2018, time=2018-07-27, status=1, ipAttribution=)]
    2018-07-29 freve
  7. [GetPortalCommentsPageByObjectIdResponse(id=1955132, encodeId=bac019551321c, content=<a href='/topic/show?id=d9db98635ef' target=_blank style='color:#2F92EE;'>#难治性抑郁症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98635, encryptionId=d9db98635ef, topicName=难治性抑郁症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea13490, createdName=xqptu, createdTime=Wed Jan 16 16:33:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998836, encodeId=3748199883693, content=<a href='/topic/show?id=4694e0110e8' target=_blank style='color:#2F92EE;'>#电惊厥疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70110, encryptionId=4694e0110e8, topicName=电惊厥疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat May 11 17:33:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1792125, encodeId=5e9c1e92125ad, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Jul 11 02:33:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334914, encodeId=0dd23349146e, content=不错了,学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sun Jul 29 12:26:23 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425882, encodeId=965f1425882b5, content=<a href='/topic/show?id=83135316192' target=_blank style='color:#2F92EE;'>#惊厥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53161, encryptionId=83135316192, topicName=惊厥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff14003523, createdName=zz12341235, createdTime=Sun Jul 29 05:33:00 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528496, encodeId=fd8215284969d, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Sun Jul 29 05:33:00 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334548, encodeId=fd8633454804, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Jul 27 18:54:22 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046576, encodeId=b25c10465e60d, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Jul 27 17:33:00 CST 2018, time=2018-07-27, status=1, ipAttribution=)]
    2018-07-27 131****1460

    学习了受益匪浅

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1955132, encodeId=bac019551321c, content=<a href='/topic/show?id=d9db98635ef' target=_blank style='color:#2F92EE;'>#难治性抑郁症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98635, encryptionId=d9db98635ef, topicName=难治性抑郁症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea13490, createdName=xqptu, createdTime=Wed Jan 16 16:33:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1998836, encodeId=3748199883693, content=<a href='/topic/show?id=4694e0110e8' target=_blank style='color:#2F92EE;'>#电惊厥疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70110, encryptionId=4694e0110e8, topicName=电惊厥疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat May 11 17:33:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1792125, encodeId=5e9c1e92125ad, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Jul 11 02:33:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334914, encodeId=0dd23349146e, content=不错了,学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sun Jul 29 12:26:23 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425882, encodeId=965f1425882b5, content=<a href='/topic/show?id=83135316192' target=_blank style='color:#2F92EE;'>#惊厥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53161, encryptionId=83135316192, topicName=惊厥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ff14003523, createdName=zz12341235, createdTime=Sun Jul 29 05:33:00 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528496, encodeId=fd8215284969d, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Sun Jul 29 05:33:00 CST 2018, time=2018-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334548, encodeId=fd8633454804, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Jul 27 18:54:22 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046576, encodeId=b25c10465e60d, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Jul 27 17:33:00 CST 2018, time=2018-07-27, status=1, ipAttribution=)]
    2018-07-27 CHANGE

    疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的

    0

相关威廉亚洲官网

Nat Genet:确定44种!研究人员首次发现众多与抑郁症相关的基因

抑郁症是世界上最严重、也最难以捉摸的公共健康问题之一,它影响到全球近15%的成年人。只有大约一半的病人对包括药物治疗和心理治疗在内的现有治疗反应良好。近日,一组科学家称已经发现了几十个增加抑郁风险的基因,这一发现突显了抑郁症的复杂性,并揭示了为什么抗抑郁治疗对某些人有效,但对其他人却完全无效。

JAMA Psychiatry:这三个位点的甲基化也许会让你患上抑郁症

据世界卫生组织统计,全球大约有3亿人患有抑郁症。尽管抑郁症的发生与遗传因素有着密切的关系,但与环境因素(如生活中的不愉快和工作上的压力)也有关。如此看来,DNA甲基化也许在老年期抑郁症中扮演重要角色。

LANCET:《柳叶刀》:缩短12倍!“3分钟疗法”可有效治疗抑郁症

4月28日,发表于国际顶级医学期刊《柳叶刀》杂志上的一项最新研究报道,在同类最大规模的研究中,一种“3分钟的大脑刺激疗法”被证明与“用于难以治疗的自闭症的标准37分钟疗法”一样有效。DOI: https://doi.org/10.1016/S0140-6736(18)30295-2

BMJ:抑郁症父亲在受孕期间需坚持服药

研究认为,受孕期父亲服用抗抑郁治疗对后代是十分安全的,不会导致后代早产、畸形、自闭症或智力障碍风险增加,相反受孕期刻意停药会导致后代智力障碍风险增加

时尚教主Kate Spade自杀:成功也不能战胜抑郁症

美国东部时间2018年6月5日,同名时尚品牌创始人兼设计师Kate Spade自杀身亡,年仅55岁。Kate Spade的丈夫Andy Spade在接受采访时表示,Kate Spade患有严重抑郁症。是的,成功如Kate Spade也会患上精神疾病。他们想内部消化 却总以自杀收场在很多人眼里,时尚icon Kate Spade就是人生赢家。不仅创立了自己的时尚王国,还有一起创业的丈夫和女儿的陪伴。

JAMA Pediatr:初为人父的新爸爸也会得产后抑郁症

一说起产后抑郁,一般williamhill asia 会认为这是新妈妈可能会经历的问题,殊不知它也会缠上初为人父的新爸爸。